Squarepoint Ops LLC Celldex Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 74,010 shares of CLDX stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
74,010
Previous 163,007 54.6%
Holding current value
$2 Million
Previous $6.03 Million 58.32%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $2.85 Million - $3.97 Million
-88,997 Reduced 54.6%
74,010 $2.51 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $1.79 Million - $2.32 Million
54,517 Added 50.25%
163,007 $6.03 Million
Q1 2024

May 15, 2024
BUY
$35.22 - $51.88 $3.2 Million - $4.72 Million
90,936 Added 518.04%
108,490 $4.55 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $131,929 - $237,192
5,835 Added 49.79%
17,554 $696,000
Q2 2023

Aug 14, 2023
BUY
$30.29 - $38.28 $354,968 - $448,603
11,719 New
11,719 $397,000
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $179,403 - $293,064
6,458 New
6,458 $287,000
Q2 2022

Aug 15, 2022
BUY
$20.5 - $37.33 $1.61 Million - $2.92 Million
78,345 New
78,345 $2.11 Million
Q1 2022

May 16, 2022
SELL
$27.64 - $39.32 $569,494 - $810,149
-20,604 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$35.68 - $56.27 $378,386 - $596,743
10,605 Added 106.06%
20,604 $796,000
Q3 2021

Nov 15, 2021
BUY
$28.95 - $55.99 $289,471 - $559,844
9,999 New
9,999 $540,000
Q2 2021

Aug 16, 2021
SELL
$20.71 - $35.37 $931,846 - $1.59 Million
-44,995 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$16.19 - $29.91 $1.13 Million - $2.09 Million
-69,769 Reduced 60.79%
44,995 $927,000
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $1.22 Million - $1.85 Million
81,382 Added 243.79%
114,764 $2.01 Million
Q3 2020

Nov 16, 2020
BUY
$9.65 - $15.19 $322,136 - $507,072
33,382 New
33,382 $495,000
Q2 2019

Aug 14, 2019
SELL
$2.43 - $5.09 $29,475 - $61,741
-12,130 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$3.45 - $10.35 $41,848 - $125,545
12,130 New
12,130 $60,000

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.26B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email